Eisai Oncology Live Webinar Series

13 Jun

DEFINE & OPTIMIZE the Role of Lenvatinib in the Treatment Strategy for HCC

13 June 2023

7:30pm - 9:30pm (GMT+9)

Registration Form
* Mandatory field

Please register in English only

This session is open for registration to the following countries only: Hong Kong, Korea, Malaysia, Philippines, Singapore and Taiwan.
Country*

First name*
Last name*
Organisation*
Email Address*
Re-enter Email Address*
By submitting your registration, you agree for Eisai Co., Ltd and its related corporations and/or third-party service providers – MCI Group Asia Pacific, event organizer on behalf of Eisai Co., Ltd (collectively referred to as ‘Eisai’) to collect, store and/or process your personal data for the purpose of the live webinar. Please see our Privacy Policy for details.
I consent to receive marketing, advertising and promotional material from, and the conduct of consumer, marketing-related and other similar research and analysis by Eisai and to each of them collecting, using, disclosing, storing, retaining and processing all my personal data in accordance with the terms in this form and the Privacy Policy. I consent to Eisai disclosing my personal data to independent third-parties and their representatives to process my personal data for such purposes.
I understand that I may withdraw one or more consents that was given, at any time by sending an email to [email protected].